Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Purification and Desalting of Plasmid DNA Using Monolith Columns.

Electrophoresis·2026
Same author

Production and Purification of Mesenchymal Stem Cell-Derived Extracellular Vesicles Using Preferential Exclusion Chromatography.

Electrophoresis·2026
Same author

Controlling In Vitro mRNA Polyadenylation by Monitoring Poly(A) Polymerase Consumption of ATP.

International journal of molecular sciences·2026
Same author

Mechanistic Insights into AAV Capsid-Stationary Phase Interactions Governing Native Stability and Chromatographic Separation Using AAV8 as a Model System.

Pharmaceutics·2026
Same author

Optimization and scale up strategies for reproducible AAV enrichment step on CIMmultus<sup>®</sup> QA HR line.

Gene therapy·2026
Same author

A two-dimensional hyphenated ion-exchange chromatographic platform for simultaneous assessment of AAV8 capsids and impurity fingerprinting in upstream processes.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026

Related Experiment Video

Updated: Nov 20, 2025

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.1K

Multiple-Monitor HPLC Assays for Rapid Process Development, In-Process Monitoring, and Validation of AAV Production

Pete Gagnon1, Blaz Goricar1, Nina Mencin1

  • 1BIA Separations, Sartorius Company, Mirce 21, 5270 Ajdovscina, Slovenia.

Pharmaceutics
|January 22, 2021
PubMed
Summary
This summary is machine-generated.

Enhanced high-performance liquid chromatography (HPLC) methods improve adeno-associated virus (AAV) characterization. Combining UV, fluorescence, and light scattering offers more accurate empty and full capsid ratio determination for therapeutic drug development.

Keywords:
AAVHPLCadeno-associated virusempty capsidsextrinsic fluorescencefull capsidsin-process analysisintrinsic fluorescencelight scatteringprocess developmentvalidation

More Related Videos

Automated Hydrophobic Interaction Chromatography Column Selection for Use in Protein Purification
10:21

Automated Hydrophobic Interaction Chromatography Column Selection for Use in Protein Purification

Published on: September 21, 2011

44.6K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.0K

Related Experiment Videos

Last Updated: Nov 20, 2025

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.1K
Automated Hydrophobic Interaction Chromatography Column Selection for Use in Protein Purification
10:21

Automated Hydrophobic Interaction Chromatography Column Selection for Use in Protein Purification

Published on: September 21, 2011

44.6K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.0K

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Biotechnology

Background:

  • High-performance liquid chromatography (HPLC) is crucial for characterizing adeno-associated virus (AAV) empty and full capsids.
  • UV-based monitoring in HPLC often overestimates full capsids and is limited for unpurified samples.

Purpose of the Study:

  • To enhance HPLC utility for characterizing therapeutic adeno-associated virus (AAV) drug substances.
  • To improve the accuracy of empty and full capsid ratio determination.
  • To enable better monitoring of DNA contamination during AAV purification.

Main Methods:

  • Combined dual-wavelength UV monitoring with intrinsic fluorescence, extrinsic fluorescence (Picogreen), and light scattering.
  • Applied enhanced HPLC methods to anion exchange (AEC), cation exchange (CEC), and size exclusion chromatography (SEC).
  • Utilized intrinsic fluorescence for sensitive AAV detection and objective capsid ratio estimation.
  • Employed light scattering for AAV identification in complex samples and semiquantitative capsid ratio analysis.
  • Used extrinsic Picogreen fluorescence for semiquantitative tracking of DNA, including host DNA contamination.

Main Results:

  • Intrinsic fluorescence enhanced AAV detection sensitivity and improved empty/full capsid ratio accuracy.
  • Light scattering allowed identification of AAV in complex matrices and semiquantitative ratio determination.
  • Extrinsic Picogreen fluorescence enabled DNA tracking throughout purification, detecting external DNA and host contamination.
  • The combined methods provide comprehensive characterization of AAV samples.

Conclusions:

  • Enhanced HPLC methods significantly improve the characterization of adeno-associated virus (AAV) products.
  • These advanced techniques offer more accurate assessment of empty and full capsid ratios.
  • The developed methods support accelerated process development, in-process monitoring, and validation for therapeutic AAV drugs.